Group 2 May 2, 2017 Session V
Session V – Empire A: Infectious Disease Evaluators: Louis Portas, Lebanon VAMC; Sharon Blum, Winthrop Univ; Jacqueline Costantino, South County Health 1:20 pm Danan, Eleanor Use and effectiveness of peri-operative cefoxitin or cefotetan versus cefazolin The Johns Hopkins plus metronidazole for prevention of surgical site infection in abdominal surgery patients 1:40 pm Effendi, Muhammad Evaluation of antimicrobial stewardship interventions and acceptance rate in a Yale New Haven Hosp large tertiary academic medical center
2:00 pm Rebrin, Nastja Time Out! Implementation of pharmacist-driven antimicrobial stewardship Baystate Med Center huddles on general medicine floors at an academic medical center 2:20 pm Liu, Erica Optimizing ciprofloxacin use for suspected urinary tract infections: reducing Yale New Haven Hosp inappropriate use and the risk of C. difficile infection 2:40 pm Steiner, Roman Evaluation of initial vancomycin dosing strategy for complicated infections in patients 36 Christiana Care to 50 years of age with normal renal function
Session V – Empire B: Infectious Disease Evaluators: Rose O’Flynn, Philadelphia VAMC; Amanda Sowell, The Johns Hopkins Hosp; Joleen Bierlein, Maine Med 1:20 pm Cabanas, Gregory Clinical outcomes with the use of fosfomycin for the treatment of Klebsiella Jersey Shore pneumoniae carbapenemase (KPC) urinary tract infections (UTIs) 1:40 pm Sangiovanni, Ryan Re-treatment with vancomycin (VAN) and subsequent risk of acute kidney injury Albany Stratton VAMC (AKI) among Veterans’ Affairs patients who have previously experienced vancomycin-associated AKI 2:00 pm Meanor, Caitlin Removing Penicillin Allergies: A Pharmacist Assessment and Skin Testing Service Carilion Clinic 2:20 pm Sheridan, Ashley Evaluating the impact of antimicrobial drug shortages on the utilization of Penn Presbyterian alternative agents and patient outcomes at an academic medical center 2:40 pm Nguyen, Nghia Impact of a Beta-Lactam Allergy Label on Initial Therapy Selection in the Johns Hopkins Emergency Department Bayview
Session V – Empire C: Quality Assurance Evaluators: Lakshmi Singh, VAMHCS; John Papadopoulos, NYU Langone; Kathleen Belusko, UMass Mem 1:20 pm Lenox, Demi Evaluation of 4-Factor Prothrombin Complex Concentrate Prescribing and Einstein Network Administration Practices 1:40 pm Kibler, Alexandra Safety and efficacy of emergent doses of intravenous levetiracetam in a Penn State Hershey neurological patient population 2:00 pm Vogel, Brittany Influence of a 90 day, $0 mail-order Medicare Part D benefit design on Kaiser Mid-Atlantic medication adherence. 2:20 pm Noss, Kelsey Comparison of prescribing and monitoring habits when ordering two QTc- Einstein Network prolonging agents before and after pharmacist-driven education 2:40 pm Kurian, Jason Evaluation of somatostatin analogs for the prevention of post-operative The Johns Hopkins pancreatic fistula Hosp
Group 2 04/21/2017
Session V – Empire D: Quality Assurance Evaluators: Jennifer Kunkel, Hahneman; Amy Nathenson, JH Home Care; Liz O’Gara, Lahey Hosp 1:20 pm Park, Jiyeon Impact of standardized infliximab dose rounding in an outpatient infusion center Englewood 1:40 pm Adedokun, Evaluation of vancomycin dosing and monitoring at an urban, community Adetokunbo hospital in Washington, D.C.: A pre- and post-intervention study Howard Univ Hosp 2:00 pm Bender, Regis Rituximab-induced lung toxicity in patients treated for non-Hodgkin’s lymphoma: Penn State Hershey a retrospective cohort study 2:20 pm Soto-Aviles, Adriana Comparison of day and night shift sedative and analgesic use in a community Suburban Hosp hospital intensive care unit 2:40 pm Pak, Diana Evaluation of acute stroke care management at a community teaching hospital Moses Taylor
Session V – Magnolia A: Cardio/Crit Care Evaluators: Jason Mordino, Boston Med Cent; Craig Worby, Dartmouth-Hitchcock; Albert Celidonio, Paoli Hosp PGY2 Evaluator: Regina Yun 1:20 pm Para, Lauren Prescribing patterns of guideline-directed medical therapy following admission Geisinger Med Center for heart failure decompensation 1:40 pm McIntyre, Kelsey Evaluation of the use of platelet function testing in patients receiving P2Y12 Christiana Care inhibitors following percutaneous coronary intervention 2:00 pm Gosek, Katarzyna Evaluating the Impact of Pharmacist-Led Management of Warfarin Therapy Using Penn Presbyterian a Standardized Process While Offering Individualized Assessment of INR Control at an Academic Medical Center: A Pilot Study 2:20 pm Ferenz, Michael Risk factors associated with development of acquired long-QT syndrome and Kennedy Univ Hosp subsequent impact on hospital length of stay and mortality 2:40 pm McMahon, Clare Impact of in-house platelet factor-4 assay on direct thrombin inhibitor use in Carilion Clinic patients with suspected heparin-induced thrombocytopenia
Session V – Magnolia B: TOC Evaluators: Nancy Nystrom, Maine Medical; Denise Fu, JH Home Care; Mark Freebery, UMD Eastern Shore 1:20 pm Megano, Danielle Evaluation of the impact of pharmacist-led motivational interviewing on patients Baystate Med Center with chronic obstructive pulmonary disease exacerbations 1:40 pm Bhatt, Krupa Pharmacy initiative to improve outpatient bridging with enoxaparin in patients Tufts with newly-implanted ventricular assist devices 2:00 pm Lee, Yeo Impact of pharmacist interventions at discharge on hospital readmission rates St. Vincent's Med Cent 2:20 pm Chin, Candice Delivery of discharge medications to patients at bedside: evaluation of the Meds- Elliot Health System to-Beds program 2:40 pm Fitzgerald, Daniel The impact of pharmacy services on care transitions to a sub-acute rehabilitation Hunterdon Med Cent facility
Group 2 04/21/2017
Session V – Magnolia C: Disease State Mgt Evaluators: Gina Waibel, Reading Hospital; Daryn Norwood, MUMH; AnneMarie Sherwood, Kaiser Mid-Atlantic PGY2 Evaluator: Anita Wong, Maryland VAHCS 1:20 pm McKimmy, Danielle Implementation of health system specialty pharmacy services: a post-transplant Yale New Haven Hosp medication management model 1:40 pm Vysotski, Sora Impact of a clinical pharmacist’s interventions on diabetes control in patients Kingsbrook Jewish with type 2 diabetes mellitus in central Brooklyn 2:00 pm Song, Chelsey Comparison of Bivalirudin and Argatroban Therapy for Patients with The Johns Hopkins Suspected/Confirmed Heparin-Induced Thrombocytopenia Hosp 2:20 pm LeGrand, Meighan Assessing anticoagulation control using time within therapeutic Range (TTR) Howard Univ Hosp 2:40 pm Davidovits, Chava Use of oral antidiabetic medications for inpatient management of type 2 diabetes Kingsbrook Jewish
Session V – Magnolia D: Ambulatory Care Evaluators: Sarah Pierce, VAMHCS; Amanda Sturges, Lebanon VAMC; Emily Pherson, The Johns Hopkins Hospital PGY2 Evaluator: Taryn Mondiello, VA Hudson Valley 1:20 pm Saafan, Yasmin Glycemic outcomes after discharge from a pharmacist run Patient Aligned Care JJP VAMC Team (PACT) clinic 1:40 pm Woskov, Joanne- Benefits of a specialty hepatitis c pharmacy within a hospital ambulatory clinic Ritzelle MWHC 2:00 pm Natali, Kayla Evaluation of diabetes-related health outcomes in patients managed by the St. Joseph's Regional ambulatory care pharmacist 2:20 pm Chaudhry, Maheen Adherence rates following implementation of a pharmacist led direct oral Cooley Dickenson anticoagulants clinic 2:40 pm Ebron, Jasmine Evaluating the clinical pharmacists’ impact on medication adherence and clinical Kaiser Mid-Atlantic outcomes in type 2 diabetic patients.
Session V – Wildrose A: Ambulatory Care Evaluators: Catherine Sanchez Vega, VAMHCS; Heather Spoonhower, Wilkes-Barre VAMC; Lois Lee, Fredrick Memorial PGY2 Evaluator: Sean Lasota, The Johns Hopkins Hosp 1:20 pm Tolbard, Dallas Evaluation of improving access to naloxone and assessing veterans’ level of Hunter Holmes comfort with naloxone in a Veterans Affair medical center McGuire VAMC 1:40 pm Quinn, Rachel Pharmacist-driven step-down of long term proton pump inhibitor therapy VA Hudson Valley 2:00 pm Mangione, Elise Standardizing the medication procurement process in the ambulatory clinic Yale New Haven Hosp setting 2:20 pm Yu, Victoria Use of a quality assurance tool (International Classification of Diseases, Tenth Hunter Holmes Revision code surveillance) to improve identification and reporting of adverse McGuire VAMC drug events associated with use of anticoagulants at a Veterans’ Affairs Medical Center 2:40 pm Argento, Liliana Evaluation of heart failure clinic at the James J. Peters VA Medical Center JJP VAMC Group 2 04/21/2017
Session V – Wildrose B: Oncology Evaluators: Genevieve Kumapley, St. Peter’s Univ Hosp; Joseph Stuccio, Paoli Hosp; Suzanne Nesbit, The Johns Hopkins Hosp 1:20 pm Robusto, Lindsay Incidence of intractable nausea and vomiting in non-small-cell lung cancer Johns Hopkins (NSCLC) patients receiving moderate-emetogenic chemotherapy regimens Bayview 1:40 pm Goscicki, Breana Time to first antibiotic administration in adult oncology patients that present to Lehigh Valley the emergency department and infusion centers 2:00 pm Dunn, Danielle Evaluating the impact of granulocyte colony-stimulating factor on bleomycin- Maine General induced pulmonary toxicity 2:20 pm Kaitharath, Megha Evaluation of efficacy and toxicity profiles of two liposomal doxorubicin Montefiore Med Cent formulations - Doxil™ and Lipodox™ - a retrospective analysis 2:40 pm Attilio, Mark Assessment of Immunosuppression in Allogeneic Stem Cell Transplantation and Penn State Hershey Risk for Graft versus Host Disease (GvHD)
Session V – Crystal A: Pharmacokinetic Evaluators: Avni Desai, St. Peter’s Univ Hosp; Kiyo Yoda, Paoli Hosp; Angela Olenik, Kaiser Mid-Atlantic 1:20 pm Oh, Jenny Phenytoin and fosphenytoin loading dose appropriateness in a community Capital Health teaching hospital 1:40 pm Chowdhury, Shehrin Vancomycin dosing in obese patients: effect of a BMI specific volume of Centra Health distribution on serum levels 2:00 pm Hadginske, Matthew Effectiveness of a modified vancomycin dosing protocol developed for obese Geisinger Wyoming patients Valley 2:20 pm McConnell, Zach Implementation and evaluation of vancomycin dosing by adjusted body weight in Henrico Doctors' Hosp obese patients 2:40 pm Naderi, Mandana Validating a standardized weight-based vancomycin dosing protocol in end stage Geisinger Wyoming renal disease patients on intermittent hemodialysis Valley
May 2, 2017 Session VI
Session VI – Empire A: Infectious Disease Evaluators: Emily Ray, Henrico Doctors’ Hosp; Lisa Scherer, Waterbury Hosp; Doug St. John, Capital Health PGY2 Evaluator: Andrew Aziz, JJP VAMC 3:30 pm Lynch, Rachel Assessment of the prescribing patterns and clinical response in the management Einstein Network of bacteremias due to carbapenem-resistant Enterobacteriaceae (CRE) 3:50 pm Lanza, David Adherence to institutional treatment guidelines and outcomes for community or Kennedy Univ Hosp hospital-acquired pneumonia in a three hospital health system 4:10 pm O’Keefe, Jillian Restricting meropenem use in a community hospital: a retrospective review of a Cooley Dickenson pharmacist-driven stewardship intervention 4:30 pm Nanduri, Aparna Characterization of Treatments for Second and Subsequent Recurrences of VAMHCS Clostridium difficile Infections in a Veteran Population 4:50 pm Hendrick, Sarah Emergency department urinalysis orders resulting in antibiotic therapy for long Kent Hospital term care facility patients with asymptomatic bacteriuria 5:10 pm Kumar, Priyana Evaluating outcomes after implementation of a new vancomycin dosing protocol MUMH at a community hospital
Group 2 04/21/2017
Session VI – Empire B: Infectious Disease Evaluators: Amanda Volpe, St. Vincent’s Med; Maritsa Serlemitsos-Day, Howard Univ Hosp; JeanMarie Perch, Penn Presbyterian; PGY2 Evaluator: Stephanie Shulder, The Johns Hopkins Hosp 3:30 pm Kim, Gee Efficacy of secondary prophylaxis with enteral vancomycin in prevention of NYU Langone recurrent Clostridium difficile infection in critically ill patients 3:50 p m Ambrose, Robert Implementation of GeneXpert MRSA/SA blood culture assay and its effect on St. Vincent’s Med vancomycin therapy in a community teaching hospital. Cent 4:10 pm Khalil, Karen Impact of antimicrobial stewardship intervention on antimicrobial use in non- Lahey Hospital intensive care unit patients at a community-based academic medical center using rapid organism identification 4:30 pm Shah, Megha Incidence of acute kidney injury among patients initiated on vancomycin and Hahnemann beta-lactam combination therapies 4:50 pm Hsu, Chih-Wei Evaluating the time to first dose of antibiotics after sepsis diagnosis in a MUMH community teaching hospital 5:10 pm Cooper, Sinead Impact of pharmacy interventions on length of stay for UTI patients at a rural Western MD Health hospital
Session VI – Empire C: Quality Assurance Evaluators: Monique Bonhomme, Sibley Hosp; Stacy Dalpoas, JH Bayview; Kristin Bohnenberger, Kingsbrook Jewish 3:30 pm White, Ashley Medication use evaluation of 4-factor prothrombin complex concentrate in Maine General patients on vitamin K antagonists 3:50 p m Pathickal, Sherin Analysis of predicted benefits through incorporating rapid identification testing Suburban Hosp for gram positive blood cultures in an acute care, community hospital 4:10 pm McPherson, Assessment of vasopressin ordering and administration practices before and Alexandra after a pharmacydriven educational initiative Einstein Network 4:30 pm Bernice, Fidelia Evaluation of Prophylactic Antibiotic Use for Implantable Cardioverter The Johns Hopkins Defibrillators Hosp 4:50 pm Reider, Christopher Analysis of protocol adherence for utilizing smart pumps to bolus continuous UMass Memorial infusion medications in critical care areas 5:10 pm Ko, You Pharmacist-managed inpatient dofetilide program: description and adherence Maine Med Center rate post-root cause analysis
Group 2 04/21/2017
Session VI – Empire D: Cardio/Crit Care Evaluators: Jason Laskosky, Lehigh Valley; Caitlin Mullins, Tufts; Tin Lic, Christiana Care PGY2 Evaluator: James Kidd, Baystate Medical Center 3:30 pm Patel, Bhakti Heparin resistance in critically ill patients Lahey Hospital 3:50 p m Graham, Allison Heparin infusion monitoring: anti-factor Xa versus activated partial Carilion Roanoke thromboplastin time Mem Hosp 4:10 pm Doan, Lyly Evaluation of Cangrelor Use in a Large Tertiary Care Hospital MWHC 4:30 pm Arnouk, Serena Clinical effects of amiodarone dosing and transition strategies in critically ill adult NYU Langone patients 4:50 pm Yap, Christopher Analysis of a pharmacy-led protocol to convert patients newly initiated on St. Joseph's Regional warfarin for non-valvular atrial fibrillation or venous thromboembolism to a non- vitamin K antagonist oral anticoagulant 5:10 pm Choi, David Evaluating the discontinuation rate of dofetilide therapy for QTc prolongation or The Johns Hopkins torsades Hosp
Session VI – Magnolia A: Medication Safety Evaluators: Kristen Fink, Kaiser Mid-Atlantic; Jill Rebuck, Penn State Hershey; Rosemary Duncan, The Johns Hopkins Hosp PGY2 Evaluator: Eileen Langstraat, The Johns Hopkins Hosp 3:30 pm Pchelka, Tom Conversion from volume-based dosing to strength-based dosing Baystate Med Center 3:50 p m Patel, Milan Pharmacy discharge medication reconciliation in an academic medical center Yale New Haven Hosp 4:10 pm West, Ashley Process improvement for allergy documentation in a best of breed electronic UMass Memorial health record system 4:30 pm Neeler, Sarah Retrospective review on effectiveness of seizure control in patients switched Kaiser Mid-Atlantic from brand to generic antiepileptic drugs in an integrated healthcare delivery system 4:50 pm Kucher, Oksana Assessing potential barriers to safe and effective inpatient opioid use Yale New Haven Hosp 5:10 pm St. Onge, Jonathan Optimizing timely administration of medications through pharmacist intervention Yale New Haven Hosp
Group 2 04/21/2017
Session VI – Magnolia B: Ambulatory Care Evaluators: Paul Abourjaily, Tufts; Kevin Sullivan, JJ Peters VAMC PGY2 Evaluator: Chelsea Sampadian, Providence VAMC 3:30 pm Halabi, Rola Benefits of a clinical pharmacist in diabetes disease state management MWHC 3:50 p m Patel, Trina Assessing appropriate physician monitoring with patients on direct oral Wilkes-Barre VAMC anticoagulants 4:10 pm Memmer, Krystal Utilization of a monthly Direct Oral Anticoagulant (DOAC) monitoring report to Hunter Holmes evaluate adherence and assess reasons for non-adherence at a Veterans Affairs McGuire VAMC Medical Center 4:30 pm Barbour, Laured Process for Converting Anticoagulation Clinic Patients Treated for a Venous JHH Home Care Group Thromboembolism to a Direct Oral Anticoagulant 4:50 pm Donald, Ta-Seti Evaluation of Outcomes in Specialty Pharmacy Management of Hepatitis C Pennsylvania Hosp 5:10 pm Shults, Carina Decreasing fluoroquinolone prescribing for uncomplicated infections Wilkes-Barre VAMC
Session VI – Magnolia C: Psychopharmacy Evaluators: Megan Flinchum, Kingsbrook Jewish; Melissa Shiner, CMC VAMC; Juliana Zschoche, The Johns Hopkins Hosp 3:30 pm Goldberg, Mayer Efficacy and safety of modafinil or armodafinil in stimulating awareness and Kingsbrook Jewish arousal in traumatic brain injury patients. 3:50 p m Wirkowski, Peter Zolpidem given for the arousal of comatose patients in the intensive care unit Winthrop Univ 4:10 pm Cooler, Jordan Clinical pharmacist intervention in an adult psychiatric unit: a pilot study Centra Health 4:30 pm Shah, Tulsi Examining the clinical outcomes of inpatients and outpatients treated with Monmouth Med aripiprazole once-monthly, a long-acting injectable antipsychotic Center 4:50 pm Stolz, Brigitte Characterization of utility of sedative hypnotics and evaluation of prescribing Hunter Holmes pattern alignment with current evidence based medicine for the treatment of McGuire VAMC insomnia in patients over the age of 75 at the McGuire Veterans Affairs Medical Center 5:10 pm Bauerlein, Deanna Prazosin prescribing patterns for veterans with posttraumatic stress disorder VAMHCS (PTSD) at the Veterans Affairs Maryland Health Care System (VAMHCS)
Group 2 04/21/2017
Session VI – Magnolia D: Education / Informatics / Card Evaluators: Vince Lacroce, Penn State Hershey; Michael Vozniak, HUP; Megan Famodu, Kaiser Mid-Atlantic PGY2 Evaluator: Jesse Feammelli, The Johns Hopkins Hosp 3:30 pm Kathuria, Nainy Implementation of a medication reference guide to improve patient education Hunterdon Med Cen 3:50 p m Jones, Kara Examining the impact of pharmacy students in reducing unhealthy behaviors Boston Med Center associated with alcohol and substance use 4:10 pm Chew, Serena Expanding the pharmacy practice advancement initiative through student Yale New Haven engagement in direct patient care activities Health 4:30 pm Samudralwar, Rahul Applicability of an electronic data reporting tool for pharmacy reporting in a Yale New Haven Hosp health system 4:50 pm Brumfield, Parker Developing an electronic pharmacy application to streamline delivery of MWHC information at a large tertiary care hospital 5:10 pm Cho, Joanne Impact of pharmacist delivered post-discharge telephone follow-up calls on VAMC - New Jersey reducing heart failure readmission rates
Session VI – Wildrose A: General Clinical Evaluators: Elsen Jacob, JHH Bayview; Margaret Curtin, Howard County Gen Hosp PGY2 Evaluator: Michael Casias, Hunterdon MC 3:30 pm Paris, Meaghan Achievement and maintenance of therapeutic levels through optimization of the Boston Med Center vancomycin protocol: a quality improvement initiative 3:50 p m DiLoreto, Stefanie Incidence of heparin resistance in patients diagnosed with heparin-induced Maine Med Center thrombocytopenia 4:10 pm Mathew, Sheena Evaluating heparin dosing regimens using total body weight with a dose cap MUMH versus adjusted body weight in obese patients at a community hospital 4:30 pm Andrawes, Monica Evaluation of the impact of order set modifications on heparin protocol Dartmouth-Hitchcock compliance in a tertiary care academic medical center 4:50 pm Bye, Kelcymarie Defining the role of the patient aligned care team pharmacist Lebanon VAMC 5:10 pm Loi, Kaitlyn Electronic health record optimizations to reduce medication use variances in Yale New Haven Hlth renal replacement therapy
Session VI – Wildrose B: Emergency Med Evaluators: Sarah Livings, Penn State Hershey; Jamie Rosini, CCHS; Kelly Bolesta, Geisinger Wyoming Valley PGY2 Evaluator: Francis Manuel, The Johns Hopkins Hosp 3:30 pm Yang, David Assessment and implementation of a protocol for direct oral anticoagulant use in St. Joseph's Regional the outpatient management of thromboembolism in eligible low-risk patients 3:50 p m Woloszczuk, Larissa Managing acute bleeds with four-factor prothrombin complex concentrate and AtlantiCare fresh frozen plasma at a community teaching center 4:10 pm Pires, Emilie Reducing drug expenditure through therapeutic interchange to nebulized Baystate Med Center respiratory treatments in outpatient areas 4:30 pm Fagnan, Matthew Formal massive hemorrhage protocol implementation and associated patient Englewood care outcomes 4:50 pm Kim, Hyunah Protocol for Intravenous Antibiotics Interchange to Oral Antibiotics in Emergency Fredrick Memorial Department 5:10 pm Cushing, Marissa Evaluation of pharmacists’ attendance during medical resuscitations in a Paoli Hospital community hospital
Group 2 04/21/2017
Session VI – Crystal A: Miscellaneous Evaluators: Michele Musheno, Moses Taylor; Ken Bevenour, Geisinger Wyoming Valley; Bryna Ewachiw, JH Bayview 3:30 pm Bourret, Scott Inventory management: the impact of National Drug Code (NDC) standardization Yale New Haven Hosp across a health-system
3:50 p m Iredell, Benjamin Evaluation of options and financial impact in replacing an automated syringe filler The Johns Hopkins robot Hosp 4:10 pm Larson, Todd Metabolic and cardiovascular complications associated with hypomagnesaemia Montefiore Med following orthotopic liver transplantation Center 4:30 pm Dunn, Kanika Evaluating the success of achieving therapeutic vancomycin trough levels with Winthrop Univ existing dosing guidelines in pediatric inpatients 4:50 pm David, Tosin Observed outcomes from incorporating medication reconciliation into a UMD Eastern Shore pharmacist‐led diabetes education program in a rural community pharmacy 5:10 pm Baker, Chezka Impact of Individualized Adherence Interventions for Solid-Organ Transplant JHH Home Care Patients with Low Medication Possession Ratio (MPR) Group
May 3, 2017 Session VII
Session VII – Empire A: Infectious Disease Evaluators: Jeff Reitz, Christianna Care; Meredith Bremer, Hunter Holmes McGuire VAMC; Michelle Kelley, Kent Hosp 8:00 am Fong, Karen Optimal duration of therapy for ventilator-associated tracheitis caused by non- NYU Langone lactose fermenting Gram-negative rods in the pediatric intensive care unit 8:20 am Aziz, Andrew A Evaluation of the efficacy of double-carbapenem therapy against carbapenem- JJP VAMC resistant Enterobacteriaceae and Pseudomonas aeruginosa infections 8:40 am Timmons, Veronica An evaluation of provider-chosen antibiotic indications as a targeted Johns Hopkins antimicrobial stewardship intervention. Bayview 9:00 am Riddick, LaTasha Concordance of outpatient antibiotic prescribing with the guidelines for the Maine Med Center treatment of acute uncomplicated cystitis in southern Maine 9:20 am Wagner, Lauren Pharmacist interventions to reduce the risk of Clostridium difficile infection Yale New Haven Hosp 9:40 am
Group 2 04/21/2017
Session VII – Empire B: Infectious Disease Evaluators: Jasmine Sudhakar, Suburban Hosp; Kimberly Allison, VA Hudson Valley; Dorothy McCoy, St. Joseph’s Regional MC; 8:00 am O'Brien, Marisa Evaluation of vancomycin dosing in obese patients at a tertiary academic medical UMass Memorial center. 8:20 am Goertel, Aubrey Determination of secondary encounter rates for urinary tract infections in Lehigh Valley patients treated with cephalexin 8:40 am Vo, Annh Management of aspiration pneumonia with and without clindamycin AtlantiCare 9:00 am Bailey, Emily Analysis of cefepime dosing before and after implementation of an antimicrobial Carilion Roanoke dosing protocol and clinical decision support tool Mem Hosp 9:20 am Porreca, Ann Marie Adherence to quality of care indicators in the management of Staphylococcus Temple aureus bacteremia 9:40 am Puskovic, Ivan De-escalation of broad spectrum anti-pseudomonals seventy two hours after Crescenz VAMC initiation
Session VII - Empire C: Quality Assurance Evaluators: Joanna Rhieu, Yale New Haven; Angela Slampak-Cindric, Geisinger Med Cen; Elora Hllmas, Dupont 8:00 am Chirico, Jacqueline Development of a pharmacy-driven penicillin skin testing program to optimize Pennsylvania Hosp the selection of antibiotics in patients with self-reported penicillin allergy 8:20 am Hancock, Christine Naltrexone long acting injectable utilization and impact on alcohol detoxification Crescenz VAMC hospitalizations 8:40 am Giordano, Brianne Optimization of isoproterenol use during electrophysiology ablations Yale New Haven Hosp 9:00 am Obi, Uzoma Evaluation of the pharmacist’s role in the management of drug-induced QTc Sibley Memorial prolongation in the inpatient setting at a community hospital 9:20 am D'Silva, Amy Venous thromboembolism prophylaxis point prevalence study Yale New Haven Hosp 9:40 am Dragic, Lisa Quality Assurance Alcohol Monitoring by Urine Ethyl Glucuronide Screen in Albany Stratton Patients Receiving Chronic Opioid Therapy (COT) VAMC
Group 2 04/21/2017
Session VII – Empire D: Cardio/Crit Care Evaluators: Angela Cheng, Montefiore Med Cen; Spencer Lee, NY Presby Brooklyn; Lauren Chychota, Einstein Med Cen PGY2 Evaluator: Sarah Jung, Christiana Care Health Syst 8:00 am Oxley, Morgan Neuromuscular blocker effect on cooling time in targeted temperature Carilion Roanoke management Mem Hosp 8:20 am Mogul, Amanda Comparison of enoxaparin and dalteparin for the use of perioperative bridging in Albany Stratton hypercoagulable patients VAMC 8:40 am Bhimani, Priya Safety and efficacy of atypical antipsychotics as adjunct treatment for alcohol Temple withdrawal in the surgical intensive care unit 9:00 am Solomon, Edmond Evaluation of albumin usage after implementation of a policy and order form in a UMass Memorial tertiary medical center. 9:20 am Dane, Kathryn Re-initiation of morbidity and mortality reducing medications during transitions The Johns Hopkins of care following cardiac surgery Hosp 9:40 am Massey, Kyle Cisatracurium dose finding in medical intensive care unit patients with acute HUP respiratory distress syndrome
Session VII – Magnolia A: Medication Safety / Cardio Evaluators: Cindy Halas, Penn State Hershey; Ryan Attwood, Cooley Dickenson; Rosemary Duncan, The Johns Hopkins Hospital 8:00 am Patel, Ammie Direct oral anticoagulants (DOACs) in post-operative atrial fibrillation (POAF) Jersey Shore following coronary artery bypass graft (CABG) surgery 8:20 am Jammal, Nadya A pharmacist-driven, multifaceted approach to standardizing anticoagulation Yale New Haven Hosp practices across a healthcare delivery network 8:40 am Berescu, Loredana Impact of pharmacy technicians to gather a best possible medication history Howard County Gen (BPMH) on medication discrepancies in a community hospital Hosp 9:00 am Lordan, Andrea Assessment of a pharmacist-driven initiative to reduce inpatient falls in a Paoli Hospital community hospital 9:20 am Lerz, Francis Reducing admission errors with medications that have multiple dosage forms Waterbury Hospital 9:40 am Farley, Stephen JCV titers in multiple sclerosis (MS) patients treated with rituximab, fingolimod Winthrop Univ and dimethyl fumarate at an American MS center: a pilot study
Group 2 04/21/2017
Session VII – Magnolia B: Ambulatory Care / Quality Evaluators: Merid Belayneh, VAMHCS; Amy Kurzatkowski, St. Vincent’s; Kevin Koons, Lenanon VAMC PGY2 Evaluator: Elizabeth Flippin, Maryland VAHCS 8:00 am Arif, Waqas Evaluation of continuous infusion midazolam, propofol, and ketamine in New York Methodist refractory status epilepticus in the intensive care unit 8:20 am Goncalo, Christopher Initiating direct oral anticoagulants through the use of clinical video Providence VAMC teleconference software at the Providence VA Medical Center (PVAMC) – a new clinic startup. 8:40 am Rumyantsev, Sandra Assessing pharmacist impact on long- term use of proton pump inhibitors in an Reading Hospital ambulatory clinic 9:00 am Cunio, Jessica Ambulatory practice advancement initiative at Yale New Haven Hospital: Yale New Haven Hosp Development and implementation of pharmacist collaborative practice agreements in the primary care clinics 9:20 am Kunkel, Holland IMPACT OF PHARMACIST-LED COUNSELING ON 30-DAY HOSPITAL READMISSION Wilkes-Barre VAMC RATES IN PATIENTS WITH CONGESTIVE HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9:40 am Tasnim, Nissa Optimizing anticoagulation therapy for the treatment of deep vein thrombosis Reading Hospital and pulmonary embolism in a hospital based pharmacist managed anticoagulation clinic
Session VII – Magnolia C: Oncology / Miscellaneous Evaluators: Brian Waldron, St. Luke’s; Jeffrey Sivik, Penn State Hershey; Genevieve Kumapley, Penn State Hershey 8:00 am Darko, Kwame Evaluating the use of double gram negative coverage in septic patients in the Waterbury Hosp emergency department 8:20 am Kee, Michael Incidence and risk factors associated with tacrolimus-induced posterior reversible HUP encephalopathy syndrome in allogeneic hematopoietic cell transplant recipients 8:40 am Xiang, Elaine Anticoagulation prescribing patterns in patients with malignancy at a large NYU Langone academic medical center 9:00 am Zou, Mei Evaluation of carboplatin toxicity and efficacy using different body weight Lahey Hospital descriptors in the Calvert formula 9:20 am Scheel, Jill Implementation and analysis of a standardized, pharmacist-monitored protocol Tufts for vaccination of adult patients after hematopoietic stem cell transplantation 9:40 am Banks, Spencer Efficacy of highly emetogenic chemotherapy protocols: palonosetron vs Fredrick Memorial granisetron
Group 2 04/21/2017
Session VII – Magnolia D: Leadership Evaluators: Christopher Gathier, Maine General MC; Ann Verghese, VA NJ; Justin Hare, WVU 8:00 am Goldenhorn, Michael Assessing the feasibility and need for an ambulatory care anticoagulation The Johns Hopkins pharmacy technician 8:20 am Welsh, Chelsea Standardizing USP 800 Education Across a Multisite Health System Yale New Haven Hlth 8:40 am Hassoun, Lynn Development and implementation of a standard process for STAT medication Boston Med Center administration 9:00 am Avino, Laura Development and implementation of a competency management system for the The Johns Hopkins Department of Pharmacy Hosp 9:20 am Sheth, Soumil Implementation of a pharmacist-driven medication counseling program Howard County Gen Hosp 9:40 am Patel, Sajani Satisfaction of medication reconciliation completed by pharmacy technicians in Monmouth Med the emergency department Center
Session VII – Wildrose A – Transplant Evaluators: Ashley Quintili, Penn State Hershey; Sandra Aguero, Einstein Med Cen; Craig Worby, Dartmouth- Hitchcock 8:00 am Tesfaye, Helen Comparison of proton pump inhibitors versus histamine-2 receptor antagonists Lahey Hospital on Clostridium difficile infection rates in liver transplant recipients 8:20 am Dao, Ann Impact of baseline characteristics on graft rejection after kidney transplantation Temple 8:40 am Hinojosa, Randall Evaluation of Enteral Ribavirin Versus Aerosolized Ribavirin in the Treatment of The Johns Hopkins Respiratory Viral Infections in Hospitalized Immunocompromised Adult Patients Hosp 9:00 am Hamel, Stephanie Use of granulocyte colony-stimulating factor (G-CSF) in leukopenic patients post- HUP kidney transplantation 9:20 am Mandal, Sana Evaluation of risk factors for Clostridium difficile in hematopoietic stem cell Temple transplant recipients 9:40 am Bandali, Aiman Duration of perioperative antimicrobial prophylaxis in orthotopic liver Hahnemann transplantation (OLT) patients
Group 2 04/21/2017
Session VII – Wildrose B – Pediatrics Evaluators: Toshiba Morgan-Joseph, Montefiore Med Cen; Kathleen Kopcza, Baystate; Ken Shermock, The Johns Hopkins Hosp 8:00 am Cherqaoui, Hanan Role of the pediatric cardiologist in medically clearing children for the use of Winthrop Univ stimulant and antipsychotic medications 8:20 am Litsas, Monica Gentamicin for neonatal sepsis: Is our empiric dosing protocol producing target Maine Med Center gentamicin concentrations? 8:40 am Lardizabal, Carla- Design, implementation, and evaluation of a multimodal pain pathway for Camille pediatric Tufts patients undergoing posterior spinal fusion surgery for adolescent idiopathic scoliosis 9:00 am Palummo, Jaclyn Safety of long-term use of dexmedetomidine in critically ill pediatric patients Jersey Shore 9:20 am Espeland, Anna Comparison of morphine dosing protocols for neonatal abstinence syndrome Elliot Health System 9:40 am Nguyen, Vy Implementation and assessment of a novel pharmacy/nursing patient discharge Dupont program
Session VII – Crystal A – Geriatrics / Pain Evaluators: Lama Kanawati, MWHC; Kimberly Keefer, Penn State Hershey; Melinda Martlind, Care New England PGY2 Evaluator: Nastaran Yazdi, The Johns Hopkins Hosp 8:00 am Diep, Kimvi Increasing naloxone access and education in a large academic medical center Yale New Haven Hosp 8:20 am Greco, Alexandra Multimodal pain management and the effect on opioid use following Carilion Clinic general/trauma surgery in patients not admitted to the intensive care unit 8:40 am Avraham, Ovadyah Implementation of proton pump inhibitor deprescription protocol in geriatric Kingsbrook Jewish residents 9:00 am James, Sara Use of ramelteon for reduction of as needed antipsychotics in elderly patients Winthrop Univ with delirium requiring constant observation 9:20 am Haase, Jamie Evaluation of pharmacist-intervention to reduce polypharmacy in the community JJP VAMC living center (CLC) 9:40 am Scalise, Alissa Evaluation of the association between chronic proton pump inhibitor use and Providence VAMC dementia at the Providence Veterans Affairs Medical Center
Group 2 04/21/2017
May 3, 2017 Session VIII
Session VIII – Empire A – Infectious Disease Evaluators: Travis Reinaker, Einstein Med Cen; Faith Wellings, Moses Taylor; Jonathan Dubyk, Carilion Roanoke PGY2 Evaluator: Randall Hinojosa, The Johns Hopkins Hosp 10:20 am Jaber, Nora Rewriting the guidelines: Uncovering methicillin-resistant Staphylococcus aureus Winthrop Univ in ventilator-associated pneumonia 10:40 am Mason, Matt Determining prescriber guideline adherence for infectious diarrhea using a rapid- Christiana Care diagnostic nucleic acid identification tool for enteric pathogens 11:00 am Lauver, Bradley Risk of hospital-acquired Clostridium difficile enterocolitis following treatment Geisinger Med Center with cefepime or piperacillin/tazobactam: a retrospective chart review 11:20 am Sessa, Julia Enhanced efficacy of high dose oral vancomycin: shortened duration of Winthrop Univ Clostridium difficile diarrhea therapy in hospitalized adults not responding to conventional oral vancomycin dosing 11:40 am Choe, Justine Risk of acute kidney injury when vancomycin is combined with Kingsbrook Jewish piperacillin/tazobactam versus meropenem or cefepime in the critical care setting
Session VIII – Empire B – Infectious Disease / Practice Research Evaluators: Dan Payne, Centra; Sharon Mindel, Hahneman; Meghan Kamrada, Carilion Clinic 10:20 am Vider, Etty The utilization of doxycyline plus ceftriaxone for inpatient treatment of Kingsbrook Jewish community acquired pneumonia in a community hospital setting 10:40 am Salovin, Tyler Implementation of reminder software in the operating room and its effect on the HUP appropriate re-dosing of intra-operative antimicrobials 11:00 am Green, Erika Clinical outcomes and costs associated with removing a combination long-acting PerformRx beta-agonist and inhaled corticosteroid product from the formulary in managed care Medicaid plans 11:20 am Villamor, Jessah Cost implications with utilizing a five-percent versus ten-percent dose rounding St. Luke's Univ policy for biologic antineoplastic agents 11:40 am Avanessians, E Analysis of tighter control of buprenorphine-containing products and its effect on PerformRx utilization for Medicaid plans
Session VIII – Empire C – Quality Assurance Evaluators: Stephanie Puckett, Centra; Yogini Patel, Pennsylvania Hosp; Andrea Weeks, Paoli Hosp 10:20 am Fadhil, Nibal Medication use evaluation of methylnaltrexone versus alvimopan in the Waterbury Hospital treatment of postoperative constipation 10:40 am Picot-Vierra, Lionel Leveraging medication history technicians in a pre-operative practice setting Yale New Haven Hosp 11:00 am Bejou, Nika Use of azithromycin in lieu of erythromycin as a cost effective method for Yale New Haven Hosp gastroparesis and visualization prior to esophagogastroduodenoscopy 11:20 am Nguyen, Kimmy Drug use evaluation to limit fluoroquinolone use for urinary tract infections in the Crescenz VAMC outpatient setting 11:40 am Knapp, Catherine Pharmacy-driven optimization of automated dispensing cabinets VA Hudson Valley
Group 2 04/21/2017
Session VIII – Empire D – Cardio / Crit Care Evaluators: Peter Hughes, Elliot Health; Ralph Riello, Yale New Haven; Daniel Longyhore, Nesbitt SOP Wilkes 10:20 am West, Lucianne Evaluation of the prescribing patterns of P2Y12 inhibitors at an academic medical The Johns Hopkins center Hosp 10:40 am Phung, Jenny Clinical implications of a nurse-driven intravenous heparin order set at a Veteran Hunter Holmes Affairs Medical Center McGuire VAMC 11:00 am Carpiniello, Philip Optimization of sedation and analgesia in mechanically ventilated patients in the Boston Med Center Cardiac Care Unit (CCU) 11:20 am Blesso, Michelle Evaluation of neuromuscular blocking agents for the prevention of shivering Dartmouth-Hitchcock during targeted temperature management post cardiac arrest 11:40 am Butler, Kristen Development and implementation of a comprehensive heparin-induced Kent Hospital thrombocytopenia protocol based on an evaluation of current management practices
Session VIII – Magnolia A – Cardio / Crit Care Evaluators: Lynne Syliva, Tufts; Michelle Kohute, Jersey Shore; Jason Laskosky, Lehigh Valley PGY2 Evaluator: David Sugrue, The Johns Hopkins Hosp 10:20 am Ahlquist, Samantha Designing a competency program for pharmacist adult medical emergency Tufts response 10:40 am Lau, Jessica Effect of lifestyle modification services on glycosylated hemoglobin in new onset Providence VAMC type 2 diabetes mellitus: a pilot study 11:00 am Kalaria, Raj Effect of midodrine on intravenous vasopressor use in a community teaching Capital Health hospital 11:20 am Yu, Yeon Intravenous bolus versus continuous infusion of loop diuretics in patients with New York Methodist acute decompensated heart failure: a retrospective analysis 11:40 am Rehmat, Shabia Evaluation of neuromuscular blocking agents (NMBAs) in the intensive care unit NY Presby Brooklyn (ICU) with a focus on adjunct therapies
Session VIII – Magnolia B – Transitions of Care Evaluators: GaEun Joung, Englewood; Hinal Patel, Hunterdon; Vi Gilmore, The Johns Hopkins Hosp PGY2 Evaluator: Jamie Haase, JJ Peters VAMC 10:20 am Blaine, Natalie Medication management at transitions of care: pharmacists’ role for improved Penn Presbyterian patient outcomes 10:40 am Reed, Chelsea Implementation of a transitions of care pharmacist at discharge following total Lebanon VAMC hip or knee arthroplasty 11:00 am Gross, Brittni Evaluation of care transitions and cost for combined corticosteroid and long- The Johns Hopkins acting beta agonist inhalers for patients admitted to an academic medical center Hosp 11:20 am Alam, Ruhaniyah Improving determination of accessibility and affordability of discharge Yale New Haven Hosp medications through electronic health record enhancements 11:40 am Clark, Stefanie Implementing a transitions of care pilot service for a low income patient Baystate Med Center population in a tertiary care medical center
Group 2 04/21/2017
Session VIII – Magnolia C: Disease State Management Evaluators: Joseph Cruz, Englewood; Joseph Reilly, AtlantiCare; Kristin Wheatley, Lehigh Valley PGY2 Evaluator: Christine Vaudo, Lahey Hosp and MC 10:20 am Liu, Lindsy Barriers to hepatitis c cascade of care in an urban hospital in Washington, D.C. Howard Univ Hosp 10:40 am Tan, Xing Evaluation of drug therapy for Clostridium difficile infection in a tertiary health St. Joseph's Regional system 11:00 am Williams, Shari Glycemic control after transitioning from standard concentration insulin to St. Luke's Univ concentrated insulin in patients with uncontrolled diabetes: A Longitudinal Case Series 11:20 am Kataria, Vivek Comparison of intravenous benzodiazepine alcohol withdrawal protocols in non- Christiana Care intensive care unit patients 11:40 am Penn, Adam Assessment of community health system protocol for adjustment of heparin drip Kennedy Univ Hosp administration based on activated partial thromboplastin time values
Session VIII – Magnolia D: Ambulatory Care Evaluators: Karen Korch Black, VAMHCS, Lauren Long, Pennsylvania Hosp; Emily Pherson, The Johns Hopkins Hospital PGY2 Evaluator: Morgan Peterman, Lebanon VAMC 10:20 am Yamazaki, Karin Evaluating potential patients for tenofovir alafenamide (TAF) regimen switch JJP VAMC 10:40 am Khan, Rimmal Pharmacist recommendations in patients with metabolic syndrome at an Reading Hospital outpatient psychiatric clinic 11:00 am Shariat, Aulia The incidence of electronic medical record medication errors in a family medicine Howard Univ Hosp outpatient clinic at a teaching hospital in Washington, D.C. 11:20 am Sorio, Monica Evaluation of glycemic control pre- and post- chronic hepatitis C treatment in a JJP VAMC diabetic veteran population 11:40 am Patolia, Roshani Impacting intranasal naloxone prescribing through pharmacist driven Boston Med Center interventions
Session VIII – Wildrose A – Oncology Evaluators: Janine Barnaby, Lehigh Valley; Douglas Hackenyos, Tufts; Adrienne Au, Temple 10:20 am Divakaruni, Anupama Monitoring and management of trastuzumab-induced cardiotoxicity at an Geisinger Med Center outpatient cancer center 10:40 am Macca, Laura Proposing a New Service: Ambulatory Infusion Center Pharmacist St. Vincent's Med Cen 11:00 am Pisano, Sorana Pharmacist-driven monitoring and education program for advanced breast Sibley cancer patients receiving palbociclib 11:20 am Brown, Erin Comparative Safety and Efficacy of Pembrolizumab Dosing-Strategies in HUP Advanced or Metastatic Melanoma Patients 11:40 am Yacobucci, Matthew Retrospective Observational Study of Clinical Outcomes in Glioblastoma Patients The Johns Hopkins with Venous Thromboembolism Hosp
Group 2 04/21/2017
Session VIII – Wildrose B – General Clinical Evaluators: Tony Rivera, Stratton VAMC; Kate Perez, VAMHCS; Patricia Grunwald, Fredrick Memorial PGY2 Evaluator: Kathryn Dane, The Johns Hopkins Hosp 10:20 am Tran, Lydia Proton pump inhibitor stewardship program: a pharmacy-driven initiative to Yale New Haven Hosp reduce inappropriate use across a health-system 10:40 am Seraphin, Megan Outcomes in patients being bridged to oral anticoagulation in atrial fibrillation Boston Med Center 11:00 am Nielsen, Kendra Efficacy and safety of high-dose thromboprophylaxis in hospitalized obese Kingsbrook Jewish patients 11:20 am Nguyen, Aimee Assessment and optimization of antibiotic dosing in patients receiving continuous Lahey Hospital renal replacement therapy 11:40 am DesJardins, Courtney Expanding the practice advancement initiative through implementation of Yale New Haven Hosp optimized pharmacy resident practice
Session VIII – Crystal A – Emergency Med Evaluators: Marc Crane, Pennsylvania Hosp; Juliana Zschoche, The Johns Hopkins Hosp; Isha John, Howard County 10:20 am Doshi, Himani Evaluation of cost associated with management of ACE inhibitor-induced Crescenz VAMC angioedema at a Veterans Affairs Medical Center 10:40 am Yohe, Alexander Impact of an electronic order set on prescribing of reversal agents for trauma Penn State Hershey surgery and neurosurgery adult patients presenting to the emergency department on oral anticoagulation 11:00 am Modh, Erika Characterizing the interventions of a pharmacy resident stationed in the Penn Presbyterian emergency department at an academic medical center: a pilot study 11:20 am Ahearn, Paul Expansion of pharmacy services in the emergency department of a large, UMass Memorial academic medical center 11:40 am Amjad, Sharmin Evaluation of pharmacological agents for sedation or analgesia in order to Temple facilitate noninvasive positive pressure ventilation in the Emergency Department
Group 2 04/21/2017